NR5A2 and metabolic dysfunction-associated steatotic liver disease: Similarly, previous studies in patients or animal models with diabetes and nonalcoholic fatty liver disease (NAFLD) have found downregulation of LRH‐1 expression in islets and the liver.34, 35